Okaya, Japan

Mitsutomo Miyashita

This inventor holds 5 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1990-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsutomo Miyashita. Retrieved from https://idiyas.com/inventor/mitsutomo-miyashita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1990-1995

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mitsutomo Miyashita: Innovator in Pharmaceutical Chemistry

Introduction

Mitsutomo Miyashita is a prominent inventor based in Okaya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on innovative chemical compounds that have potential applications in medicine.

Latest Patents

Miyashita's latest patents include groundbreaking research on N,N'-disubstituted amide derivatives and cyclic anthranilic acid derivatives. These inventions highlight his expertise in developing new chemical processes and compounds that can lead to advancements in therapeutic treatments.

Career Highlights

Mitsutomo Miyashita is associated with Kyorin Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His dedication to innovation has positioned him as a key figure in the industry, contributing to the development of new medications and therapies.

Collaborations

Miyashita has collaborated with notable colleagues, including Fukutaro Taga and Hiroshi Matsukubo. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Mitsutomo Miyashita's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as an influential inventor in the field. His work continues to pave the way for future innovations in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…